A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 31/00 (2006.01) A61M 37/00 (2006.01)
Patent
CA 2743781
An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.
L'invention concerne un système d'activation thérapeutique pouvant être ingéré et un procédé. Selon un aspect, ce système d'activation comprend un dispositif pouvant être ingéré à module effecteur capable d'envoyer une instruction effectrice et un module répondant associé à un dispositif thérapeutique. Le module répondant peut recevoir et traiter l'instruction effectrice, ce qui entraîne une réponse de la part du dispositif thérapeutique. Parmi les réponses du dispositif thérapeutique, on peut citer l'activation thérapeutique, la désactivation thérapeutique, la modulation thérapeutique et l'interruption thérapeutique.
Colliou Olivier
Jensen Marc
Strand Angela
Zdeblick Mark
Proteus Biomedical Inc.
Ridout & Maybee Llp
LandOfFree
Ingestible therapy activator system and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ingestible therapy activator system and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ingestible therapy activator system and method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1733655